Trial Outcomes & Findings for RIPC During Free Flap With Preoperative Radiotherapy (NCT NCT03535623)

NCT ID: NCT03535623

Last Updated: 2026-06-11

Results Overview

tissue oxygen saturation of the flap

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

44 participants

Primary outcome timeframe

postoperative day 1

Results posted on

2026-06-11

Participant Flow

Participant milestones

Participant milestones
Measure
Remote Ischemic Conditioning
Remote ischemic conditioning (RIC) consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the RIPC group. remote ischemic conditioning (RIC): RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion.
Sham
Sham-RIC consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the Sham-RIPC group. Sham-RIC: Sham-RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion.
Overall Study
STARTED
22
22
Overall Study
COMPLETED
20
19
Overall Study
NOT COMPLETED
2
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

RIPC During Free Flap With Preoperative Radiotherapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Remote Ischemic Conditioning
n=20 Participants
Remote ischemic conditioning (RIC) consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the RIPC group. remote ischemic conditioning (RIC): RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion.
Sham
n=19 Participants
Sham-RIC consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the Sham-RIPC group. Sham-RIC: Sham-RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion.
Total
n=39 Participants
Total of all reporting groups
Age, Continuous
65 years
n=20 Participants
65 years
n=20 Participants
65 years
n=40 Participants
Sex: Female, Male
Female
6 Participants
n=20 Participants
5 Participants
n=20 Participants
11 Participants
n=40 Participants
Sex: Female, Male
Male
14 Participants
n=20 Participants
14 Participants
n=20 Participants
28 Participants
n=40 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Asian
20 Participants
n=20 Participants
19 Participants
n=20 Participants
39 Participants
n=40 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
White
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=20 Participants
0 Participants
n=20 Participants
0 Participants
n=40 Participants
Region of Enrollment
South Korea
20 participants
n=20 Participants
19 participants
n=20 Participants
39 participants
n=40 Participants
Regional tissue oxygen saturation
87 %
n=20 Participants
84 %
n=20 Participants
85 %
n=40 Participants

PRIMARY outcome

Timeframe: postoperative day 1

tissue oxygen saturation of the flap

Outcome measures

Outcome measures
Measure
Remote Ischemic Conditioning
n=20 Participants
Remote ischemic conditioning (RIC) consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the RIPC group. remote ischemic conditioning (RIC): RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion.
Sham
n=19 Participants
Sham-RIC consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the Sham-RIPC group. Sham-RIC: Sham-RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion.
Tissue Oxygen Saturation
87 percent
Interval 69.0 to 95.0
84 percent
Interval 74.0 to 93.0

SECONDARY outcome

Timeframe: during the study period until discharge, an average of 17.5 days

Number of participants who occurred flap complications during the study period

Outcome measures

Outcome measures
Measure
Remote Ischemic Conditioning
n=20 Participants
Remote ischemic conditioning (RIC) consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the RIPC group. remote ischemic conditioning (RIC): RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of 200 mmHg and 5-min reperfusion.
Sham
n=19 Participants
Sham-RIC consisted of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion is applied to the upper arm of the patients in the Sham-RIPC group. Sham-RIC: Sham-RIC consists of 4 cycles of 5-min ischemia using pneumatic cuff pressure of \< 10 mmHg and 5-min reperfusion.
Number of Participants With Flap Complications
4 Participants
10 Participants

Adverse Events

Remote Ischemic Conditioning

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Youn Joung Cho, MD, PhD

Seoul National University Hospital

Phone: 82-2-2072-2467

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place